Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Lidocaine Market Size study, by Type (Powder, Gel, Cream), by Application (Cosmetics, Medicine) and Regional Forecasts 2020-2027

  • BIZ4192955
  • 200 Pages
  • February 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Lidocaine Market is valued at approximately USD 893.23 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2020-2027. Lidocaine, also referred to as lignocaine, is a provincial anesthetic of the amino amide type. Lidocaine helps to reduce sharp burning pains as well as discomfort caused by skin irritations such as scratches, poison sumac, poison ivy, minor cuts, poison oak, insect bites, and sunburns. Further, lidocaine's local painkiller action foresees its use in extensive medicinal circumstances or situations that may benefit from its action, involving the treatment of impulsive ejaculation, which may reinforce the demand for lidocaine market all over the world. Also, it is frequently used in dental procedure and cosmetic surgery, for laser resurfacing after 20 minutes without occlusion. Thus, rising cosmetic surgical procedures has increased the demand for lidocaine which is primarily drives the growth of the market. For instance: as per the Victorian Cosmetic Institute, the total number of cosmetic surgical procedures in Australia estimated at around 1,790,832 in 2017 and is increased to nearly 1,811,740 in 2018. Similarly, as of 2018, nearly 53,028 Australian had done neck lifting surgery and has risen to 53,571 number of people undergone through neck lifting surgical procedure in 2019. Moreover, Lidocaine is commonly used for its anti-inflammatory actions to reduce cough and improve respiratory symptoms in severe asthmatic patients. Thus, increasing cases of chronic disease, followed by the rising geriatric population resulting in encouraging the demand for lidocaine; therefore, propelling the growth of the market. According to National Center for Biotechnology Information, generally, 33% of Chinese and 49% of Indian respondents aged 50 and older reported at least one chronic condition. As per Statista, the number of people with asthma in Australia were 2013.5 thousand people in 2005 and has risen to 2705.1 thousand peoples suffering from asthma in 2018. This, in turn, is likely to strengthen the demand for Lidocaine, thereby contributing to the market growth around the world. However, the strict regulatory standards for lidocaine is one of the prime factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Lidocaine market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing demand for lidocaine formulations, along with the wide presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in number of cometic procedures and dental procedures coupled with increasing awareness regarding lidocaine among medical practitioners in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the Lidocaine market in the Asia-Pacific region.

Major market player included in this report are:

Amneal Pharmaceuticals Inc.

AstraZeneca

Teligent

Centura Pharmaceuticals

Taro Pharmaceutical Industries Ltd.

Pfizer Inc.

Merck KGaA

SCILEX Pharmaceuticals, Inc.

Mahendra chemicals

Cirondrugs

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Powder

Gel

Cream

By Application:

Cosmetics

Medicine

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Lidocaine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)

1.2.1. Lidocaine Market, by Region, 2018-2027 (USD Million)

1.2.2. Lidocaine Market, by Type, 2018-2027 (USD Million)

1.2.3. Lidocaine Market, by Application, 2018-2027 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Lidocaine Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Lidocaine Market Dynamics

3.1. Lidocaine Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Lidocaine Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Lidocaine Market, by Type

5.1. Market Snapshot

5.2. Global Lidocaine Market by Type, Performance - Potential Analysis

5.3. Global Lidocaine Market Estimates & Forecasts by Type 2017-2027 (USD Million)

5.4. Lidocaine Market, Sub Segment Analysis

5.4.1. Powder

5.4.2. Gel

5.4.3. Cream

Chapter 6. Global Lidocaine Market, by Application

6.1. Market Snapshot

6.2. Global Lidocaine Market by Application, Performance - Potential Analysis

6.3. Global Lidocaine Market Estimates & Forecasts by Application 2017-2027 (USD Million)

6.4. Lidocaine Market, Sub Segment Analysis

6.4.1. Cosmetics

6.4.2. Medicine

Chapter 7. Global Lidocaine Market, Regional Analysis

7.1. Lidocaine Market, Regional Market Snapshot

7.2. North America Lidocaine Market

7.2.1. U.S. Lidocaine Market

7.2.1.1. Type breakdown estimates & forecasts, 2017-2027

7.2.1.2. Application breakdown estimates & forecasts, 2017-2027

7.2.2. Canada Lidocaine Market

7.3. Europe Lidocaine Market Snapshot

7.3.1. U.K. Lidocaine Market

7.3.2. Germany Lidocaine Market

7.3.3. France Lidocaine Market

7.3.4. Spain Lidocaine Market

7.3.5. Italy Lidocaine Market

7.3.6. Rest of Europe Lidocaine Market

7.4. Asia-Pacific Lidocaine Market Snapshot

7.4.1. China Lidocaine Market

7.4.2. India Lidocaine Market

7.4.3. Japan Lidocaine Market

7.4.4. Australia Lidocaine Market

7.4.5. South Korea Lidocaine Market

7.4.6. Rest of Asia Pacific Lidocaine Market

7.5. Latin America Lidocaine Market Snapshot

7.5.1. Brazil Lidocaine Market

7.5.2. Mexico Lidocaine Market

7.6. Rest of The World Lidocaine Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Amneal Pharmaceuticals Inc.

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. AstraZeneca

8.2.3. Teligent

8.2.4. Centura Pharmaceuticals

8.2.5. Taro Pharmaceutical Industries Ltd.

8.2.6. Pfizer Inc.

8.2.7. Merck KGaA

8.2.8. SCILEX Pharmaceuticals, Inc.

8.2.9. Mahendra chemicals

8.2.10. Cirondrugs

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Lidocaine market, report scope

TABLE 2. Global Lidocaine market estimates & forecasts by region 2017-2027 (USD Million)

TABLE 3. Global Lidocaine market estimates & forecasts by Type 2017-2027 (USD Million)

TABLE 4. Global Lidocaine market estimates & forecasts by Application 2017-2027 (USD Million)

TABLE 5. Global Lidocaine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 6. Global Lidocaine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 7. Global Lidocaine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 8. Global Lidocaine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 9. Global Lidocaine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 10. Global Lidocaine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 11. Global Lidocaine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 12. Global Lidocaine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 13. Global Lidocaine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 14. Global Lidocaine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 15. Global Lidocaine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 16. Global Lidocaine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 17. Global Lidocaine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 18. Global Lidocaine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 19. Global Lidocaine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 20. Global Lidocaine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 21. U.S. Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 22. U.S. Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 23. U.S. Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 24. Canada Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 25. Canada Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 26. Canada Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 27. UK Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 28. UK Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 29. UK Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 30. Germany Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 31. Germany Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 32. Germany Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 33. France Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 34. France Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 35. France Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 36. Spain Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 37. Spain Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 38. Spain Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 39. Italy Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 40. Italy Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 41. Italy Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 42. ROE Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 43. ROE Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 44. ROE Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 45. China Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 46. China Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 47. China Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 48. India Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 49. India Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 50. India Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 51. Japan Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 52. Japan Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 53. Japan Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 54. Australia Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 55. Australia Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 56. Australia Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 57. South Korea Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 58. South Korea Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 59. South Korea Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 60. ROPAC Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 61. ROPAC Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 62. ROPAC Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 63. Brazil Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 64. Brazil Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 65. Brazil Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 66. Mexico Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 67. Mexico Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 68. Mexico Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 69. ROLA Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 70. ROLA Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 71. ROLA Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 72. ROW Lidocaine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 73. ROW Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 74. ROW Lidocaine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 75. List of secondary sources, used in the study of global Lidocaine market

TABLE 76. List of primary sources, used in the study of global Lidocaine market

TABLE 77. Years considered for the study

TABLE 78. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390